Relationships of vascular endothelial growth factor (VEGFA) with stage of diabetic retinopathy and disease duration in patients with type 2 diabetes mellitus
Background: As there is currently an epidemic of type 2 diabetes mellitus (T2DM), increasing attention should be paid to diabetic retinopathy (DR), a major complication of the disease which can lead to disability and blindness. Increased levels of growth factors (mainly, vascular endothelial growth...
Saved in:
Main Authors: | A. S. Hudz (Author), G. Ie. Zakharevych (Author), O. V. Pentrenko (Author), S. V. Ziablitsev (Author), V. S. Dzhordzhua (Author) |
---|---|
Format: | Book |
Published: |
Ukrainian Society of Ophthalmologists,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Levels of neuroinflammation markers in type 2 diabetes mellitus patients with diabetic retinopathy and genetically determined hyperhomocysteinemia
by: Iu. O. Panchenko, et al.
Published: (2024) -
Topical nerve growth factor prevents neurodegenerative and vascular stages of diabetic retinopathy
by: Gianpaolo Zerbini, et al.
Published: (2022) -
Influence of local and systemic factors of type 2 diabetes mellitus on the functional status of platelets in patients with diabetic retinopathy and maculopathy
by: S.Iu. Mogilevskyy, et al.
Published: (2018) -
Predicting the risk of diabetic retinopathy-associated macular edema in patients with type 2 diabetes mellitus
by: S.Yu. Mogilevskyy, et al.
Published: (2019) -
The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
by: Yue Zhao, et al.
Published: (2018)